Pathfinders in Biopharma

Perspectives from the cutting edge of biotech and pharma.

The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series.

Lead today. Define tomorrow.

Explore the Series

Biotech SPACs: A New Route to Going Public

As more firms and investors look to SPACs as an IPO alternative, will this change the way biotech companies access public markets long-term? Our investment banking team goes inside the SPAC boom to explain what companies need to know before choosing their path to going public.

Biotech Outlook 2021: Innovation, IPOs and COVID‑19

Biotech innovation came to the fore in 2020 in the public battle to find a COVID-19 vaccine. RBC’s equity research analysts share what’s on the horizon for the sector in 2021.

Read Article

Read Time 4m

RBC Imagine: Game Changers for Biotech in 2021

COVID-19 continues to be the big potential disruptor for healthcare this year, and there could be increased pressure on new drug launches and clinical trials especially if the pandemic continues beyond the end of 2021.

Read Article

Read Time 3m

Digital Health Outlook: Accelerated innovation and adoption continues in 2021

The digitization of healthcare was already underway before 2020. But the pandemic hugely accelerated this trend, clearing regulatory barriers out of the way and getting the public comfortable with the idea of telemedicine. As investors search for value, Healthcare IT (HCIT) could be a new growth driver in tech according to RBC’s equity research analysts.

Read Article

Read Time 3m

2021 Outlook: Pharma May be Ready to Deploy M&A Firepower

After a challenging year for M&A, Randall Stanicky, Specialty and Generic Pharmaceuticals Research Analyst at RBC Capital Markets, believes advancements in coronavirus vaccines, therapeutics, and biotech could fuel a resurgence in deal-making activity for the pharmaceutical sector in 2021.

Read Article

Read Time 2m

Key Healthcare Trends to Watch in 2021: Digital Health, Gene Therapy and Neurology

Last year was a record-breaking one for biotech. At RBC Capital Markets’ 2020 Private Healthcare Company Conference, our equity research analysts highlighted key areas for investment and innovation in 2021, and how they expect the sector to maintain growth.

5AM Ventures: Fueling the Next Generation of Innovators

In this episode of Pathfinders, Brian Abrahams, Co-Head of Biotechnology Equity Research at RBC Capital Markets speaks with Andy Schwab, Co-Founder and Managing Partner at 5AM Ventures, one of the world’s leading venture capital firms focused on creating value in early-stage life science companies.

Subscribe to Future Episodes of Pathfinders

Our podcast series explores the fast-moving world of Biopharma and what the road ahead looks like for companies and investors in the sector.

Subscribe Now

Recent Deals


A Leading Partner for the Biopharma Industry

Our specialty expertise, combined with outstanding execution, has resulted in recurring transactions for biopharma clients as we partner with them through each stage of their development and growth.


More from RBC Capital Markets

Navigating the Changing Face of Healthcare

Healthcare is in the midst of a revolution. From the challenges facing individual sectors to breakthrough innovations, gain the insights you need into the forces that are reshaping the industry.

A Leader in Global Insights

Access market and industry insights, commentary and analysis from our expert team to gain the perspective you need to make the most informed decisions.

Subscribe Today

The latest in thought leadership, directly to your inbox.